Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
NCT05640024
·
clinicaltrials.gov ↗
UNKNOWN
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Sponsor
Yonsei University